Atlas Trials

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Clinical trial NCT02241720 · TERMINATED

Trial details

NCT number
NCT02241720
Sponsor
University of Utah
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Upper GI Cancer
Start date
2014-05-01
Primary completion
2016-09-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.